Gara Jalqabaatti › Leukemia Myeloidii Hamaa › California › Mountain View
Qorannoo klinikaalii Leukemia Myeloidii Hamaa Mountain View, CA keessatti
Qorannoo 19 Leukemia Myeloidii Hamaa f Mountain View fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 1
- Lucile Packard Children's Hospital /ID# 276015, Palo Alto · Miili 5 fagaatti
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Stanford Health Care, Stanford · Miili 5 fagaatti
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Namoota walitti qabaa jiraSadarkaa 3
- Lucile Packard Children's Hospital Stanford University, Palo Alto · Miili 5 fagaatti
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Namoota walitti qabaa jiraSadarkaa 2
- Stanford Cancer Institute, Stanford · Miili 5 fagaatti
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Namoota walitti qabaa jiraSadarkaa 1/2
- Lucile Packard Children's Hospital Stanford University, Palo Alto · Miili 5 fagaatti
Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 1
- Lucille Packard Children's Hospital of Stanford University, Palo Alto · Miili 5 fagaatti
TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Namoota walitti qabaa jiraSadarkaa 1
- Stanford University, Palo Alto · Miili 5 fagaatti
Niclosamide in Pediatric Patients With Relapsed and Refractory AML
Namoota walitti qabaa jiraSadarkaa 1
- Stanford University, Palo Alto · Miili 5 fagaatti
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Stanford University Medical Center, Stanford · Miili 5 fagaatti
Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
Namoota walitti qabaa jiraSadarkaa 1
- Stanford University, Palo Alto · Miili 5 fagaatti
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Namoota walitti qabaa jiraSadarkaa 1
- Stanford University, Stanford · Miili 5 fagaatti
Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford University, Palo Alto · Miili 5 fagaatti
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford University, Palo Alto · Miili 5 fagaatti
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 2
- Stanford, Palo Alto · Miili 5 fagaatti
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Namoota walitti qabaa jiraSadarkaa 1
- Stanford Medical Center, Palo Alto · Miili 5 fagaatti
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Namoota walitti qabaa jiraSadarkaa 1
- Stanford University, Stanford · Miili 5 fagaatti
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 1
- Stanford Cancer Center, Palo Alto · Miili 5 fagaatti
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford Cancer Center, Palo Alto · Miili 5 fagaatti
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Stanford University, Stanford · Miili 5 fagaatti
Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti
- Houston, TXQorannoo 85
- New York City, NYQorannoo 51
- Boston, MAQorannoo 44
- Seattle, WAQorannoo 41
- Baldwin Park, CAQorannoo 40
- Columbus, OHQorannoo 35
- Philadelphia, PAQorannoo 34
- Durham, NCQorannoo 33
- Atlanta, GAQorannoo 31
- Tampa, FLQorannoo 29
- Chicago, ILQorannoo 26
- Portland, ORQorannoo 25
Qorannoo biroo Mountain View keessatti
- Saree (Gosoota Hunda)Qorannoo 40
- Saree OljooQorannoo 26
- Kansara MetastatikiiQorannoo 25
- Kansara Qara'a Non-Small CellQorannoo 21
- Kansarii OvariiQorannoo 19
- Dhibee Spektiraamii AutisimiiQorannoo 17
- Dhibee QaraQorannoo 17
- Kansarii ProstateQorannoo 15
- Cufama OnneeQorannoo 15
- AutismQorannoo 13
- Leukemia Lymphoblasticii HamaaQorannoo 13
- Kansarii ColorectalQorannoo 13
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.